Differentiation of pulmonary from colonic adenocarcinoma by cytokeratin immunostaining

Differentiation of pulmonary and colonic adenocarcinomas1:

 

n

CK7+

CK20+

CK7+/CK20-

CK7-/CK20+

CK7+/CK20+

CK7-/CK20-

primary lung carcinoma

50

94%

6%

88%

0

6%

6%

metastatic carcinoma from a lung primary

24

96%

13%

93%

0

13%

4%

total for lung carcinoma

74

95%

8%

86%

0

8%

5%

 

primary colon carcinoma

51

16%

96%

0

80%

16%

4%

metastatic carcinoma from a colonic primary

26

31%

100%

0

69%

31%

0

total for colon carcinoma

77

21%

97%

0

77%

21%

3%

Neither CK7 nor CK20 alone reliably differentiated pulmonary from colonic carcinomas. However, the combination is reliable, with tumours that are CK7+/CK20+ or CK7-/CK20- being of indeterminate origin.

References

1Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic carcinomas. Am J Clin Pathol 1994;102:764-767.

©SMUHT/PW Bishop